Literature DB >> 21598357

Radial access site inflammatory reaction to a recently available hydrophilic coated sheath.

Rajesh V Swaminathan1, S Chiu Wong.   

Abstract

A sterile inflammatory reaction at the radial access site has been described in the literature as an adverse local reaction to Cook hydrophilic coated sheaths during transradial catheterization. To date, this reaction has not been observed with non-Cook hydrophilic sheaths. Here, we describe two cases of such a reaction with Glidesheaths™ at our institution.
Copyright © 2010 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2011        PMID: 21598357     DOI: 10.1002/ccd.22896

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Particulates from hydrophilic-coated guiding sheaths embolise to the brain.

Authors:  James R L Stanley; Abraham R Tzafriri; Kathryn Regan; Alan LaRochelle; Gee Wong; Brett G Zani; Peter M Markham; Lynn Bailey; Anna Spognardi; Gregory A Kopia; Elazer R Edelman
Journal:  EuroIntervention       Date:  2016-03       Impact factor: 6.534

Review 2.  Non-ischemic cerebral enhancing lesions secondary to endovascular aneurysm therapy: nickel allergy or foreign body reaction? Case series and review of the literature.

Authors:  Eimad Shotar; Bruno Law-Ye; Flore Baronnet-Chauvet; Sinead Zeidan; Dimitri Psimaras; Franck Bielle; Catherine Pecquet; Soledad Navarro; Charlotte Rosso; Fleur Cohen; Jacques Chiras; Federico Di Maria; Nader Sourour; Frédéric Clarençon
Journal:  Neuroradiology       Date:  2016-05-23       Impact factor: 2.804

3.  Radial access during percutaneous interventions in patients with acute coronary syndromes: should we routinely monitor radial artery patency by ultrasonography promptly after the procedure and in long-term observation?

Authors:  Anna Lisowska; Małgorzata Knapp; Agnieszka Tycińska; Piotr Sielatycki; Robert Sawicki; Paweł Kralisz; Włodzimierz J Musiał
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-22       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.